Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond Ann Surg Oncol (2018) 25:2105–2110 https://doi.org/10.1245/s10434-018-6513-7 EDITORIAL – MELANOMAS Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond 1,2 3,4,5 Jeffrey E. Gershenwald, MD and Richard A. Scolyer, MD Departments of Surgical Oncology and Cancer Biology, Unit 1484, The University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX; 3 4 Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia Melanoma staging is a critical tool for communication stage IV patients in their initial data analyses of the between physicians and their patients and also assists IMDDP. Therefore, patients eligible to be included in the clinical decision-making and prognostic assessment. It is IMDDP were those with stages I–III cutaneous melanoma used for clinical trial design, eligibility, stratification, and diagnosed since 1998. This approach allowed us to exclude analysis. Importantly, it also represents the foundation for patients diagnosed during the early and mid-1990s, a per- reporting in institutional, state, national, and international iod of rapid evolution in surgical, pathological, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Loading next page...
 
/lp/springer_journal/melanoma-staging-american-joint-committee-on-cancer-ajcc-8th-edition-FS59UQZE0N
Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-018-6513-7
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:2105–2110 https://doi.org/10.1245/s10434-018-6513-7 EDITORIAL – MELANOMAS Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond 1,2 3,4,5 Jeffrey E. Gershenwald, MD and Richard A. Scolyer, MD Departments of Surgical Oncology and Cancer Biology, Unit 1484, The University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX; 3 4 Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia Melanoma staging is a critical tool for communication stage IV patients in their initial data analyses of the between physicians and their patients and also assists IMDDP. Therefore, patients eligible to be included in the clinical decision-making and prognostic assessment. It is IMDDP were those with stages I–III cutaneous melanoma used for clinical trial design, eligibility, stratification, and diagnosed since 1998. This approach allowed us to exclude analysis. Importantly, it also represents the foundation for patients diagnosed during the early and mid-1990s, a per- reporting in institutional, state, national, and international iod of rapid evolution in surgical, pathological,

Journal

Annals of Surgical OncologySpringer Journals

Published: May 30, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off